| pubmed-article:4544776 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:4544776 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:4544776 | lifeskim:mentions | umls-concept:C0322177 | lld:lifeskim |
| pubmed-article:4544776 | lifeskim:mentions | umls-concept:C0733511 | lld:lifeskim |
| pubmed-article:4544776 | lifeskim:mentions | umls-concept:C0870160 | lld:lifeskim |
| pubmed-article:4544776 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:4544776 | pubmed:dateCreated | 1974-5-28 | lld:pubmed |
| pubmed-article:4544776 | pubmed:abstractText | Arecoline hydrobromide has been used for almost half a century for the treatment of Echinococcus granulosus in dogs. Trials in New Zealand showed that it had real limitations for this purpose. Its main value lies in its use as a diagnostic agent for detecting infections in dogs on a group basis. The data so obtained can be used in educating dog owners as well as for providing base-line data and an index of progress in a continuing control programme. The drug's limitations for treatment and value as a diagnostic agent in a field trial are assessed. | lld:pubmed |
| pubmed-article:4544776 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4544776 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4544776 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4544776 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4544776 | pubmed:language | eng | lld:pubmed |
| pubmed-article:4544776 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4544776 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:4544776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4544776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4544776 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:4544776 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:4544776 | pubmed:issn | 0042-9686 | lld:pubmed |
| pubmed-article:4544776 | pubmed:author | pubmed-author:GemmellM AMA | lld:pubmed |
| pubmed-article:4544776 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:4544776 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:4544776 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:4544776 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:4544776 | pubmed:pagination | 649-52 | lld:pubmed |
| pubmed-article:4544776 | pubmed:dateRevised | 2010-10-26 | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:meshHeading | pubmed-meshheading:4544776-... | lld:pubmed |
| pubmed-article:4544776 | pubmed:year | 1973 | lld:pubmed |
| pubmed-article:4544776 | pubmed:articleTitle | Surveillance of Echinococcus granulosus in dogs with arecoline hydrobromide. | lld:pubmed |
| pubmed-article:4544776 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4544776 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4544776 | lld:pubmed |
